Affinage

LRIT3

Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3 · UniProt Q3SXY7

Length
679 aa
Mass
74.8 kDa
Annotated
2026-06-10
15 papers in source corpus 10 papers cited in narrative 10 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 6/6 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

LRIT3 is a single-pass transmembrane protein with extracellular leucine-rich-repeat (LRR), immunoglobulin (IG), and fibronectin type III (FN3) domains that acts as a presynaptic trans-synaptic organizer of glutamatergic signaling at photoreceptor-to-bipolar-cell synapses in the retina (PMID:31189098, PMID:37091241). It is expressed presynaptically in rod and cone photoreceptors, and selectively expressing LRIT3 in Lrit3-/- rods or cones via AAV is sufficient to reassemble the postsynaptic mGluR6 signaling complex (signalplex) on depolarizing bipolar cell (DBC) dendrites and restore vision, establishing that LRIT3 organizes the postsynaptic complex across the synaptic cleft (PMID:31189098, PMID:37091241). LRIT3 localizes to DBC dendritic tips and is required for proper localization of TRPM1 at all DBCs and of mGluR6, GPR179, RGS7, RGS11, and Gβ5 specifically at cone ON-bipolar cell dendritic tips (PMID:25997951). It functions upstream of Nyctalopin, physically interacting with and being required for Nyctalopin localization, while signalplex components are not required for LRIT3 itself (PMID:31959619); domain dissection assigns the LRR domain to synaptic trafficking and trans-synaptic Nyctalopin binding and the IG domain to TRPM1 localization, with the FN3 domain dispensable (PMID:42055330). Loss of LRIT3 abolishes ON-pathway signaling and indirectly disorganizes cone ON-bipolar synaptic ultrastructure and OFF-pathway responses (PMID:28334377, PMID:31959619), and reduces retinal dopamine with impaired recovery from lens-induced myopia (PMID:39250117). Loss-of-function mutations in LRIT3 cause complete congenital stationary night blindness with an absent ERG b-wave (PMID:23246293).

Mechanistic history

Synthesis pass · year-by-year structured walk · 10 steps
  1. 2012 Medium

    Established LRIT3 as a retinal disease gene and placed its function at the ON bipolar cell, answering whether this LRR/IG/transmembrane protein had a defined site of action in vision.

    Evidence Whole-exome sequencing of CSNB patients plus anti-LRIT3 immunohistochemistry on human retina and ERG

    PMID:23246293

    Open questions at the time
    • Did not define the molecular partners or mechanism of LRIT3
    • Localization was punctate at the OPL but cell-of-origin (pre- vs postsynaptic) was unresolved
  2. 2012 Low

    Proposed LRIT3 as an FGFR1 signaling modulator via its LRR and IG domains, raising an alternative non-retinal mechanistic context.

    Evidence Biochemical interaction assays identifying LRIT3 as an FGFR1 regulator (method not detailed in abstract)

    PMID:22673519

    Open questions at the time
    • Assay details not specified and not replicated in the corpus
    • No connection established to the retinal signalplex role characterized in later work
  3. 2014 High

    Demonstrated causally that LRIT3 loss disrupts ON bipolar cell function in vivo, moving beyond correlation from patient genetics.

    Evidence Lrit3 gene-trap knockout mouse with ERG, optomotor testing, and SD-OCT

    PMID:24598786

    Open questions at the time
    • Did not identify which signalplex molecules are affected
    • Did not distinguish rod vs cone pathway contributions
  4. 2015 High

    Defined LRIT3 as a selective organizer of the DBC signalplex, identifying TRPM1 as universally LRIT3-dependent and the mGluR6/GPR179/RGS complex as cone-ON-BC-specific.

    Evidence Multi-marker immunofluorescence confocal comparison of WT vs Lrit3nob6 retina

    PMID:25997951

    Open questions at the time
    • Did not establish whether LRIT3 acts pre- or postsynaptically
    • Mechanism of differential rod vs cone dependence unresolved
  5. 2017 High

    Showed that LRIT3 loss selectively disorganizes cone ON-BC synaptic ultrastructure while OFF-BC molecular targeting is preserved, refining the pathway specificity.

    Evidence Electron microscopy, GluR1/GluR5 immunostaining, and multielectrode array recordings in Lrit3-/- mice

    PMID:28334377

    Open questions at the time
    • Did not explain how OFF-pathway signaling becomes altered
    • Trans-synaptic vs cell-autonomous mechanism still open
  6. 2019 High

    Proved LRIT3 functions presynaptically as a trans-synaptic organizer, by showing rod-specific re-expression restores the postsynaptic complex and vision.

    Evidence AAV-mediated rod-specific LRIT3 rescue in Lrit3-/- mice with signalplex immunostaining and ERG

    PMID:31189098

    Open questions at the time
    • Direct trans-synaptic binding partners not yet identified
    • Cone-specific rescue not yet tested
  7. 2020 High

    Placed LRIT3 upstream of Nyctalopin via a physical interaction and clarified the indirect mechanism of OFF-pathway disruption.

    Evidence Co-immunoprecipitation, immunofluorescence in Lrit3-/- retina, whole-cell and MEA electrophysiology, glutamate imaging

    PMID:31959619

    Open questions at the time
    • Co-IP not reported with reciprocal/structural validation
    • How OFF-BC excitatory input is reduced mechanistically not fully resolved
  8. 2023 High

    Confirmed the trans-synaptic model in the cone pathway, showing cone-specific LRIT3 re-expression reassembles the cone DBC signalplex and partially restores function.

    Evidence rAAV cone-specific LRIT3 expression in Lrit3-/- mice with ERG, BC/RGC electrophysiology, and immunostaining

    PMID:37091241

    Open questions at the time
    • Functional restoration was only partial
    • Did not map which domains mediate cone targeting
  9. 2024 Medium

    Connected LRIT3-dependent ON-pathway signaling to dopaminergic regulation of eye growth, broadening its physiological role beyond night vision.

    Evidence UPLC quantification of retinal DA/DOPAC and infrared photorefractometry under lens-induced myopia in Lrit3-/- mice

    PMID:39250117

    Open questions at the time
    • Causal link between dopamine reduction and myopia recovery not directly tested
    • Single lab, two orthogonal methods
  10. 2025 High

    Assigned distinct molecular jobs to LRIT3 domains: LRR for synaptic trafficking and Nyctalopin binding, IG for TRPM1 localization, FN3 dispensable.

    Evidence rAAV domain-deletion LRIT3 constructs in Lrit3-/- retina with signalplex immunostaining, ERG, and electrophysiology

    PMID:42055330

    Open questions at the time
    • Direct IG-TRPM1 binding inferred from a model, not shown biochemically
    • Why TRPM1 requires more than Nyctalopin restoration is unexplained

Open questions

Synthesis pass · forward-looking unresolved questions
  • The biochemical nature of LRIT3's trans-synaptic contacts and how a presynaptic protein dictates assembly of distinct postsynaptic complexes at rod vs cone synapses remain unresolved.
  • No structure of LRIT3 or its complexes
  • Direct molecular receptor for LRIT3 on the postsynaptic membrane not identified
  • Mechanism of rod vs cone signalplex specificity unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 4 GO:0098631 cell adhesion mediator activity 2
Localization
GO:0005886 plasma membrane 3
Pathway
R-HSA-112316 Neuronal System 3 R-HSA-1500931 Cell-Cell communication 2
Partners
NYXTRPM1
Complex memberships
mGluR6 signalplex

Evidence

Reading pass · 10 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2012 LRIT3 (encoding a leucine-rich-repeat, immunoglobulin-like, and transmembrane-domain protein) is expressed at the outer plexiform layer of the human retina in a punctate pattern resembling the dendritic tips of ON bipolar cells, as shown by antibody staining; loss-of-function mutations cause complete congenital stationary night blindness with absent/reduced ERG b-wave, indicating a role in ON bipolar cell signaling. Whole-exome sequencing, Sanger sequencing, immunohistochemistry (anti-LRIT3 antibody) on human retina, ERG American journal of human genetics Medium 23246293
2014 Lrit3 knockout mice (nob6) exhibit a no-b-wave (nob) ERG phenotype with severely reduced b-wave amplitudes in scotopic and photopic conditions and decreased optomotor responses, establishing that LRIT3 loss disrupts ON bipolar cell function; inner nuclear layer thinning was detected by SD-OCT without gross retinal degeneration. Lrit3 knockout mouse model (gene trap), ERG, optomotor testing, fundus imaging, SD-OCT, histology PloS one High 24598786
2015 LRIT3 localizes to the dendritic tips of depolarizing bipolar cells (DBCs) in the outer plexiform layer (OPL) and co-localizes with mGluR6 but not ribeye or calbindin. In Lrit3-/- (nob6) mice, TRPM1 localization is severely decreased at DBC dendritic tips of all DBCs, while mGluR6, GPR179, RGS7, RGS11, and Gβ5 are absent specifically at cone ON-BC (but not rod bipolar cell) dendritic tips. PNA labeling is also severely reduced in the OPL, suggesting an additional role in cone synapse formation. Immunofluorescence confocal microscopy in wild-type vs. Lrit3nob6/nob6 retinal sections using antibodies against LRIT3, TRPM1, mGluR6, GPR179, RGS7, RGS11, Gβ5, PNA, ribeye, calbindin The European journal of neuroscience High 25997951
2017 LRIT3 selectively affects cone ON-BC (but not OFF-BC) synaptic contacts at the ultrastructural level: synaptic contacts made by ON-BCs (but not OFF-BCs) with cone pedicles are disorganized in Lrit3-/- (nob6) mice, while molecules essential for OFF-BC signaling (GluR1, GluR5) are normally targeted. Multielectrode array recordings showed complete loss of ON-pathway function with retained but altered OFF-pathway signaling. Electron microscopy, immunostaining with confocal microscopy (GluR1, GluR5), multielectrode array recordings of retinal ganglion cells, ERG (patient and mouse), Lrit3-/- mouse model Investigative ophthalmology & visual science High 28334377
2019 LRIT3 is expressed presynaptically in rod photoreceptors (not only postsynaptically on bipolar cells). Restoring LRIT3 expression selectively in Lrit3-/- rods via AAV is sufficient to restore the postsynaptic DBC glutamate signalplex assembly and rod-driven vision, demonstrating that LRIT3 acts as a transsynaptic organizer of the postsynaptic complex. Immunofluorescence co-localization, AAV-mediated rod-specific LRIT3 rescue in Lrit3-/- mice, ERG, immunostaining of signalplex components Cell reports High 31189098
2020 LRIT3 interacts with and is required for the expression of nyctalopin at DBC dendritic tips; DBC signalplex components are not required for LRIT3 expression (placing LRIT3 upstream of nyctalopin). Loss of LRIT3 also reduces excitatory input to type 1 OFF bipolar cells and disrupts OFF retinal ganglion cell visually evoked responses, demonstrating an indirect effect on the OFF pathway. Co-immunoprecipitation (LRIT3-nyctalopin interaction), immunofluorescence in Lrit3-/- mouse retina, whole-cell electrophysiology, multielectrode array (MEA) electrophysiology, glutamate imaging eNeuro High 31959619
2012 LRIT3 acts as a modulator/regulator of FGFR1 signaling, identified through its LRR and immunoglobulin domains as a candidate FGFR interactor. Biochemical interaction assays (details from abstract: LRIT3 identified as FGFR1 regulator) FEBS letters Low 22673519
2023 rAAV-mediated expression of LRIT3 in cone photoreceptors of Lrit3-/- mice restores cone DBC signalplex components and partially restores downstream visual function (light-adapted ERG b-wave and BC/RGC electrophysiological responses), confirming that LRIT3 acts trans-synaptically from cones to organize the postsynaptic complex on cone DBCs. rAAV-mediated cone-specific LRIT3 expression in Lrit3-/- mice, ERG, whole-cell electrophysiology of BCs and RGCs, immunostaining of signalplex components iScience High 37091241
2024 Loss of LRIT3 and its associated ON-pathway defect drastically reduces retinal dopamine (DA) and DOPAC levels, and Lrit3-/- mice show impaired recovery from lens-induced myopia, linking LRIT3-dependent ON-pathway signaling to dopaminergic regulation of refractive development. UPLC quantification of DA and DOPAC in isolated Lrit3-/- retinas, infrared photorefractometry for refractive development, lens-induced myopia protocol Investigative ophthalmology & visual science Medium 39250117
2025 Domain deletion analysis of LRIT3 reveals: (1) the LRR domain is required for trafficking LRIT3 to the synapse in cone (but not rod) photoreceptors, and is needed for rod BC signalplex reassembly and function; (2) the IG domain is required for TRPM1 localization to the signalplex and thus function; (3) the FN3 domain is not necessary for DBC signalplex assembly or function; (4) restoring Nyctalopin localization alone is insufficient to restore TRPM1 expression. A model is proposed in which the LRR domain transsynaptically binds Nyctalopin while the IG domain interacts with TRPM1. rAAV-mediated expression of domain-deletion LRIT3 constructs in Lrit3-/- retinas, immunostaining for signalplex components (TRPM1, Nyctalopin, others), ERG, electrophysiology The Journal of biological chemistry High 42055330

Source papers

Stage 0 corpus · 15 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2012 Whole-exome sequencing identifies LRIT3 mutations as a cause of autosomal-recessive complete congenital stationary night blindness. American journal of human genetics 111 23246293
2015 LRIT3 is essential to localize TRPM1 to the dendritic tips of depolarizing bipolar cells and may play a role in cone synapse formation. The European journal of neuroscience 50 25997951
2014 Lrit3 deficient mouse (nob6): a novel model of complete congenital stationary night blindness (cCSNB). PloS one 50 24598786
2019 Presynaptic Expression of LRIT3 Transsynaptically Organizes the Postsynaptic Glutamate Signaling Complex Containing TRPM1. Cell reports 44 31189098
2022 Targeting ON-bipolar cells by AAV gene therapy stably reverses LRIT3-congenital stationary night blindness. Proceedings of the National Academy of Sciences of the United States of America 29 35316139
2020 LRIT3 is Required for Nyctalopin Expression and Normal ON and OFF Pathway Signaling in the Retina. eNeuro 28 31959619
2017 LRIT3 Differentially Affects Connectivity and Synaptic Transmission of Cones to ON- and OFF-Bipolar Cells. Investigative ophthalmology & visual science 24 28334377
2019 Genome-wide association study and whole-genome sequencing identify a deletion in LRIT3 associated with canine congenital stationary night blindness. Scientific reports 17 31578364
2012 Leucine-rich repeat, immunoglobulin-like and transmembrane domain 3 (LRIT3) is a modulator of FGFR1. FEBS letters 14 22673519
2024 Loss of ON-Pathway Function in Mice Lacking Lrit3 Decreases Recovery From Lens-Induced Myopia. Investigative ophthalmology & visual science 8 39250117
2023 Extended functional rescue following AAV gene therapy in a canine model of LRIT3-congenital stationary night blindness. Vision research 7 37220680
2023 LRIT3 expression in cone photoreceptors restores post-synaptic bipolar cell signalplex assembly and partial function in Lrit3 mice. iScience 5 37091241
2016 Mutation screening of the LRIT3, CABP4, and GPR179 genes in Chinese patients with Schubert-Bornschein congenital stationary night blindness. Ophthalmic genetics 4 27428514
2026 Domain-specific functions of LRIT3 in synaptic assembly and retinal signal transmission. The Journal of biological chemistry 0 42055330
2025 Domain-specific functions of LRIT3 in synaptic assembly and retinal signal transmission. bioRxiv : the preprint server for biology 0 41000924

Missed literature

Know a paper Affinage missed for LRIT3? Flag it for the maintainers and the community.

No submissions yet.